Publications of Karl Herholz
All genres
Journal Article (72)
2012
Journal Article
33 (5), pp. 867 - 877 (2012)
Cholinergic system function and cognition in mild cognitive impairment. Neurobiology of Aging 2010
Journal Article
96 (2), pp. 231 - 239 (2010)
[11C]-l-Methionine positron emission tomography in the management of children and young adults with brain tumors. Journal of Neuro-Oncology 2009
Journal Article
50 (12), pp. 1962 - 1968 (2009)
Methyl-L-11C-methionine PET as a diagnostic marker for malignant progression in patients with glioma. Journal of Nuclear Medicine
Journal Article
28 (3), pp. 259 - 266 (2009)
Performance of FDG PET for detection of Alzheimer's disease in two independent multicentre samples (NEST-DD and ADNI). Dementia and Geriatric Cognitive Disorders 2008
Journal Article
15 (11), pp. 1155 - 1162 (2008)
CSF total and phosphorylated tau protein, regional glucose metabolism and dementia severity in Alzheimer's disease. European Journal of Neurology
Journal Article
49 (1), pp. 44 - 49 (2008)
Cortical flattening applied to high-resolution F-18-FDG PET. Journal of Nuclear Medicine 2007
Journal Article
Evaluation of primary brain tumors using 11C-methionine PET with reference to a normal methionine uptake map. 12, pp. 1971 - 1980 (2007)
Journal Article
14 (6), pp. 690 - 693 (2007)
Imaging of acetylcholine esterase activity in brainstem nuclei involved in regulation of sleep and wakefulness. European Journal of Neurology
Journal Article
51 (2), pp. 164 - 181 (2007)
Role of in vivo imaging of the central nervous system for developing novel drugs. Quarterly Journal of Nuclear Medicine and Molecular Imaging
Journal Article
51 (2), pp. 164 - 181 (2007)
Developing novel drugs by in vivo imaging of the CNS. Quarterly Journal of Nuclear Medicine and Molecular Imaging 2006
Journal Article
408 (1), pp. 46 - 50 (2006)
Cortical acetylcholine esterase activity and ApoE4-genotype in Alzheimer disease. Neuroscience Letters
Journal Article
27 (7), pp. 588 - 597 (2006)
Neural correlates of anosognosia for cognitive impairment in Alzheimer's disease. Human Brain Mapping
Journal Article
98 (1), pp. 57 - 65 (2006)
From the left to the right: How the brain compensates progressive loss of language function. Brain and Language
Journal Article
33 (5), pp. 516 - 524 (2006)
Use of C-11-methionine PET to monitor the effects of temozolomide chemotherapy in malignant gliomas. European Journal of Nuclear Medicine and Molecular Imaging
Journal Article
30 (3), pp. 871 - 878 (2006)
Decomposition of metabolic brain clusters in the frontal variant of frontotemporal dementia. NeuroImage
Journal Article
47 (2), pp. 302 - 312 (2006)
Brain receptor imaging. Journal of Nuclear Medicine
Journal Article
21 (5-6), pp. 373 - 379 (2006)
Orbitofrontal dysfunction related to both apathy and disinhibition in frontotemporal dementia. Dementia and Geriatric Cognitive Disorders 2005
Journal Article
65 (11), pp. 1716 - 1722 (2005)
Dementia in Parkinson disease: functional imaging of cholinergic and dopaminergic pathways. Neurology
Journal Article
46 (12), pp. 1948 - 1958 (2005)
F-18-fluoro-L-thymidine and C-11-methylmethionine as markers of increased transport and proliferation in brain tumors. Journal of Nuclear Medicine
Journal Article
25 (12), pp. 1685 - 1691 (2005)
Crossed cerebellar diaschisis in acute human stroke: a PET study of serial changes and response to supratentorial reperfusion. Journal of Cerebral Blood Flow and Metabolism